Results 151 to 160 of about 37,478 (219)

Integrated management strategies for benign prostatic hyperplasia. [PDF]

Front Urol
Zhou Y, Luo Q, Wang R, Zheng D, Xiong Y, Zuo J, Wang S, Zhong L.   +7 more
europepmc   +1 more source

AI-based modeling of treatment decisions in benign prostatic hyperplasia: a transformer-based comparative study. [PDF]

BMC Med Inform Decis Mak
Alshraideh M, Alshraideh B, Alshraideh A, Alfayoumi B, HebaAlshraideh.   +4 more
europepmc   +1 more source

Exploring Sulpiride as an Alternative to Testosterone Propionate for Inducing Benign Prostatic Hyperplasia in Rodent Models. [PDF]

Toxics
Owumi S, Pius EM, Abdulganiyu HA, Alabi IO, Eso VO, Sanusi AA, Owolabi OM, Arunsi UO, Babalola JO, Otunla MT, Akomolafe AP, Olapade-Olaopa EO, Oyelere AK, Ogunwobi OO, Amadi CM.   +14 more
europepmc   +1 more source

The efficacy and safety of 1470 nm diode laser in the treatment of benign prostatic hyperplasia: a prospective, multicenter study. [PDF]

Lasers Med Sci
Xu H, Kuang W, Lin D, Li K, Luan Y, Cui K, Yang T, Chen Z.   +7 more
europepmc   +1 more source

Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling. [PDF]

Sci Rep
Alomari G, Al-Trad B, Qar J, Tahat L, Abu Haija Y, Al-Najjar A, Albokhadaim I, Shousha S, Alameen AO, Shukry M.   +9 more
europepmc   +1 more source

Diversity of Gut Microbiota and Metabolites in Benign Prostatic Hyperplasia with Different Prostate Volumes. [PDF]

Eur Urol Open Sci
Liu J, Chen Y, Wang Y, Li D, Xu Z, Zhang J, Qin L, Han B, Jing Y, Cui D, Zhu Y, Xia S, Jiang C.   +12 more
europepmc   +1 more source

Disease Progression and Outcomes in Patients With Benign Prostatic Hyperplasia: Protocol for a Multicenter Retrospective Cohort Study. [PDF]

JMIR Res Protoc
Lv Z, Liu J, Lu Y, Zhang X, Gao F, Guo B, Zhang H, Li H, Lv C.   +8 more
europepmc   +1 more source

A Case Series on the Efficacy and Safety of Transperineal Laser Ablation for Benign Prostatic Hyperplasia. [PDF]

J Clin Med
Locke MR, Locke DR.
europepmc   +1 more source

Predictors and predictive performance of immune-inflammation indices for symptom severity in benign prostatic hyperplasia. [PDF]

Sci Rep
Kassaw AB, Abdu SM, Abebe G.
europepmc   +1 more source

Non-invasive prediction of detrusor underactivity in benign prostatic hyperplasia: an interpretable machine learning framework to optimize surgical selection. [PDF]

Front Med (Lausanne)
Gao L, Luo Z, Yuan Y, Luo Z, Zhuang H, Gao J, Xie X.   +6 more
europepmc   +1 more source